| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Benzalkonium chloride |
Is a |
False |
Benzalkonium (substance) |
Inferred relationship |
Some |
|
| Benzalkonium adverse reaction |
Causative agent (attribute) |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Allergy to benzalkonium (finding) |
Causative agent (attribute) |
False |
Benzalkonium (substance) |
Inferred relationship |
Some |
|
| Product containing benzalkonium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium and cetrimide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium and dimeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium and hexylresorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzalkonium (substance) |
Inferred relationship |
Some |
|
| Product containing benzalkonium in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzalkonium (substance) |
Inferred relationship |
Some |
|
| Allergy to benzalkonium (finding) |
Causative agent (attribute) |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzododecinium (substance) |
Is a |
False |
Benzalkonium (substance) |
Inferred relationship |
Some |
|
| Benzalkonium chloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
|
| Product containing benzalkonium in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing benzalkonium and dimeticone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium- and tolnaftate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium- and cetrimide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and cetrimide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and dimeticone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and hexylresorcinol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and tolnaftate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and cetrimide only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and dimeticone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and tolnaftate only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzalkonium in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzalkonium in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium- and polyethylene-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium and polyethylene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzalkonium and polyethylene in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium- and polyethylene-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzalkonium (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]